Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows From Operating Activities:
Net loss	$ (11,694,569)	$ (8,891,977)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	1,264,138	36,502
Accretion of financing costs	1,172,349	282,624
Amortization of right-of-use asset	25,261	25,264
Unrealized loss on investment		6,322
Stock-based compensation	3,171,116	3,369,269
Shares issued for professional services		(132)
Change in fair value of derivative liability	(705,184)
Change in fair value of conversion option	250,304
Change in fair value of liability-classified equity-linked contracts	(9,016)
Loss on extinguishment of debt	675,648
Loss on private placement	567,161
Changes in operating assets and liabilities:
Accounts receivable	54,000
Inventory	(101,577)	(246,571)
Grants receivable	64,666	(270,783)
Prepaid expenses and deposits	1,167,375	788,140
Other current assets		(242,850)
Accounts payable and accrued liabilities	(1,454,022)	385,208
Net Cash Used in Operating Activities	(5,552,350)	(4,758,984)
Cash Flows From Investing Activities:
Other acquisition deposits		(693,667)
Acquisition of property, equipment, and water rights	(863,158)	(6,477,131)
Purchase of water rights/intangible assets		(101,300)
Net Cash Used in Investing Activities	(863,158)	(7,272,098)
Cash Flows From Financing Activities:
Proceeds from issuance of common shares through At-The-Market offering	6,882,758
Proceeds from subscription agreements (Note 13)	1,900,000
Proceeds from exercise of share purchase warrants		37,500
Proceeds from notes payable, net of issuance costs		20,472,496
Principal paid on notes payable	(3,600,000)	(7,800,000)
Proceeds from share purchase agreement, net of issuance costs		2,380,050
Net Cash Provided by Financing Activities	5,182,758	15,090,046
Increase (decrease) in Cash	(1,232,750)	3,058,964
Cash – Beginning of Period	7,001,786	2,320,149
Cash – End of Period	$ 5,769,036	$ 5,379,113